You can narrow down the results using the filters
-
A single-group pilot trial evaluating the effect of pre-procedural chewables on gastric volume and ease of fasting in children undergoing surgery (JELLYFISH - Phase One)
Expand descriptionPre-operative fasting is an important part of preparing for anaesthesia. Fasting reduces the volume and acidity of the stomach contents, which serves to reduce the risk of regurgitation and pulmonary aspiration. Fasting can be particularly stressful for young children, which can in turn lead to negative psychosocial and physiological outcomes. In this study, we wish to investigate if a pre-procedural carbohydrate-based chewables can help children to better tolerate pre-operative fasting.
-
A randomised controlled trial of pre-procedural chewables to help children fasting for surgery (JELLYFISH - Phase Two)
Expand descriptionPre-operative fasting is an important part of preparing for anaesthesia. Fasting reduces the volume andacidity of the stomach contents, which serves to reduce the risk of regurgitation and pulmonary aspiration. Fasting can be particularly stressful for young children, which can in turn lead to negative psychosocial and physiological outcomes. In this study, we wish to investigate if a pre-procedural carbohydrate-based chewables can help children to reduce the negative effects of pre-operative fasting. We hope to provide evidence that these chewables are able to help kids tolerate fasting by improving their fasting discomfort, and reduce their post-operative nausea and vomitting.
-
Acceptability and feasibility of community (home-based) self-sampling of Australian adults with influenza-like illness: A pilot study
Expand descriptionThis research study tests whether people, who are feeling unwell with an influenza-like illness, find swabbing themselves at home to be an acceptable method of detecting influenza and other viruses. Patients experiencing cough, fever, and fatigue will be provided with a home-swab kit by their GPs. After they swab themselves at home, patients will return the swab by post to the pathology provider, and answer survey questions about their experience.
-
BLUEPRINT: Predicting Long-term Outcomes of Prematurity from Early Life Events
Expand descriptionMost babies born preterm have breathing problems shortly after birth, and many need help with their breathing. Clinicians have many treatments to help preterm babies breath, and know which treatments works best for most babies. But clinicians don’t know which treatments will work best for each baby. The BLUEPRINT Study aims to provide a more precise picture (phenotype) of how a specific preterm baby’s lungs are working in the first 7 days after birth. This will be achieved by combining information on the clinical care being used, measurements of lung function and the pattern of proteins in the blood collected 3 and 7 days after birth. We will then follow babies through until 2 years of age to measure their lung growth and function. By understanding the different lung phenotypes that exist in preterm babies, we hope to help doctors know which treatments may be best for a baby and predict which baby might be at more risk for lung problems as they grow up.
-
Implementation and evaluation of co-designed strategies with Aboriginal and Torres Strait Islander women aiming to reduce diabetes-related risks before, during and after pregnancy
Expand description -
A Phase 1 randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetics of single ascending doses and multiple ascending doses of SION-451 in healthy participants
Expand descriptionThis is a Phase 1, first-in-human (FIH), randomised, double-blind, placebo controlled study to evaluate the safety, tolerability, and pharmacokinetics (PK) of single ascending doses (SAD) and multiple ascending doses (MAD) of SION-451 administered as an oral suspension in healthy participants.
-
A Phase 1 randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability. and pharmacokinetics of single ascending doses and multiple ascending doses of SION-451 in healthy participants - Part C
Expand descriptionThis is a Phase 1 study to evaluate the effect of food on the PK of SION-451 and the bioequivalence of a tablet formulation compared with the oral suspension formulation in healthy participants.
-
A study on the Bonsai Sensor on participants with or without Obstructive Sleep Apnoea (OSA) to assess signal parameters
Expand descriptionThis is a prospective study to assess signal parameters of the Bonsai Sensor across different builds or design iterations of the device. Up to 60 participants will be recruitment to achieve total of 300 nights of recordings for each sub-study. Participants with or without diagnosis of Obstructive Sleep Apnoea will be screened and enrolled.
-
An Interventional Trial for Persisting Post-Concussive Symptoms after Mild Traumatic Brain Injury
Expand descriptionThis purpose of this study is to examine whether new brain training regimes (active interventions) can influence brain function and reduce persistent post-concussion symptoms. This study will compare two different types of brain training to the “standard treatment”, which for mTBI is no treatment other than symptom management (control with no intervention). This will aid in determining whether people in the brain training groups have less symptoms because of brain training, or whether they would have had a reduction in symptoms anyway during that time.
-
A trial of iCamperdown - an online treatment for adults who stutter.
Expand descriptionResearchers at the Australian Stuttering Research Centre have developed an online speech treatment program—iCamperdown—for adults who stutter. iCamperdown is an online version of the Camperdown Program, an evidence-based treatment for adults who stutter. iCamperdown is designed to teach adults who stutter a way to learn to control their stuttering without seeing a speech pathologist. The purpose of this study is to assess the safety of the iCamperdown Program, to evaluate compliance and preliminary treatment outcomes.